Determination of mass attenuation coefficient by numerical absorption calibration with Monte-Carlo simulations at 59.54 keV

International audienceThis study presents a numerical method in order to determine the mass attenuation coefficient of a sample with an unknown chemical composition at low energy. It is compared with two experimental methods : a graphic method and a transmission method. The method proposes to realise a numerical absorption calibration curve to process experimental results. Demineralised water with known mass attenuation coefficient (0.2066 cm 2 .g −1 at 59.54 keV) is chosen to confirm the method. 0.1964 ± 0.0350 cm 2 .g −1 is the average value determined by the numerical method, that is to say less than 5% relative deviation compared to more than 47% for the experimental methods

Determination of plutonium in nitric acid solutions using energy dispersive L X-ray fluorescence with a low power X-ray generator

International audienceThis work presents the development of an in-line energy dispersive L X-ray fluorescence spectrometer setup , with a low power X-ray generator and a secondary target, for the determination of plutonium concentration in nitric acid solutions. The intensity of the L X-rays from the internal conversion and gamma rays emitted by the daughter nuclei from plutonium are minimized and corrected, in order to eliminate the interferences with the L X-ray fluorescence spectrum. The matrix effects are then corrected by the Compton peak method. A calibration plot for plutonium solutions within the range 0.1-20 g.L −1 is given

Beam characterization of a lab bench cold cathode ultra-soft X-ray generator

International audienceThe aim of this work is to characterize the Ultra Soft X-ray (USX, 1.5 keV, Al Kα) photon beam of a customized lab bench cold cathode generator. Within this generator, the electron beam is slowed down in a thin aluminium foil (16 μm) supported by an easily exchangeable anode. It is shown that the thickness of the foil and the anode configuration determine the spatial distribution and the fluence rate of the photon beam, whereas accelerating voltage determines both fluence rate and energy spectrum feature. It is shown also that under specific operation parameters (i.e. accelerating voltage), a Gaussian energy distribution of the beam can be generated which is centred on the energy of the Al Kα line (1.5 keV). Dosimetric films of GAFCHROMIC® HD-810 were used to estimate the photon fluence rate distribution of the beam. Its variation, when the generator acts as a monoenergetic source, was characterized with the two different configurations of the anode assembly. Finally, it is verified that the anode assembly consisting in a flat washer, on which the aluminium foil is set, acts as a simple point-source

Well GeHP detector calibration for environmental measurements using reference materials

International audienceA well-type detector installed in the Modane underground Laboratory (LSM) can combine both low background and high detection efficiency and it is well suited for the analysis of small amounts of environmental samples. Reference materials such as IAEA-447 (moss-soil), IAEA-RG-Th1 and IAEA-RG-U1 were used for the detector calibration, owing to a chemical composition close to those of the environmental samples. Nevertheless , the matrix effects and the true coincidence summing effects must be corrected from the full energy peak efficiency (FEPE). The FEPE was performed for a wide range of energy by a semi-empirical method using Monte Carlo simulation (MCNP6), intended for environmental measurements such as lake sediments dating. In the well geometry, the true coincidence summing effects could be very important and correction factors have been computed in three different ways

Mesures de spectrométrie et de dosimétrie neutron aux postes de travail pour l'étalonnage de dosimètres individuels PGP-DIN

International audience(ManuAcrit r e p le 3 juillet 2002, accepté le 29 septembre 2002) Dans le cadre de la mise en application des recommandations décrites dans la publication 60 de la CIPR, des mesures de spectrométrie neutron ont été réalisées à plusieurs postes de travail au CEA de Valduc. Le but de ces mesures était la détermination de nouveaux coefficients d'étalonnage h affecter aux dosimètres individuels neutron PGP-DIN afin de restituer correctement les doses reçues par les opérateurs séjournant h ces postes. Ces mesures ont été effectuées au cours de deux campagnes successives. La tluence neutronique et le débit d'équivalent de dose amhiantH*(IO) ont été mesurés en fonction de l'énergie avec le spectromètre ROSPEC et un système de sphères de BONNER. Les champs de radiations étant toutefois mixtes, c'est-à-dire présentant une composante neutronique et photonique, des mesures de débits d'équivalent de dose ambiant photon aux postes de travail considérés ont également été réalisées à l'aide de débitmètres d'ambiance. Les dosimètres individuels PGP-DIN ont été positionnés sur un fantôme (ISO) d'eau. Des calculs effectués h l'aide du code MCNP ont été comparés aux résultats expérimentaux. Neutron spectrometry and dosimetry measurement at workplaces for calibration of individual PGP-DIN dosimeters. Measurements to determine new coefficients for individual neutron dosimeters PGP-DIN complying with the ICRP 60 recommendations were performed at two workplaces at the CEA of Valduc: a storage r w m and a plutonium reprocessing plant. Two spectrometry campaigns were performed allowing a better assessment of doses received by operators worki.ng at these workplaces. Neutron energy fluence and ambient dose equivalent rate H*(10) distributions were measured as function of neutron energy by using the ROSPEC device and BONNER spheres spectrometer. The radiation field being mixed neutron and gamma, the gamma component was also evaluated: neutron and photon dose-rate meters were nsed to evaluate the ambient dose rate equivalent. Individual dosemeters were positioned on an ISO water slab phantom. In addition, calculations were performed using the MCNP simulation code for different configurations. ' Insiitui de radioprotection ct de sûre16 nucléaire, DPHD, B.P. 17. 92262 Fontcnay-aux-Roses Cedcx, France

Non-targeted Stressful Effects in Normal Human Fibroblast Cultures Exposed to Low Fluences of High Charge, High-Energy (HZE) Particles: Kinetics of Biologic Responses and Significance of Secondary Radiations.

International audienceThe induction of nontargeted stressful effects in cell populations exposed to low fluences of high-charge (Z) and high-energy (E) particles is relevant to estimates of the health risks of space radiation. We investigated the up-regulation of stress markers in confluent normal human fibroblast cultures exposed to 1,000 MeV/u iron ions [linear energy transfer (LET) ∼151 keV/μm] or 600 MeV/u silicon ions (LET ∼50 keV/μm) at mean absorbed doses as low as 0.2 cGy, wherein 1-3% of the cells were targeted through the nucleus by a primary particle. Within 24 h postirradiation, significant increases in the levels of phospho-TP53 (serine 15), p21(Waf1) (CDKN1A), HDM2, phospho-ERK1/2, protein carbonylation and lipid peroxidation were detected, which suggested participation in the stress response of cells not targeted by primary particles. This was supported by in situ studies that indicated greater increases in 53BP1 foci formation, a marker of DNA damage. than expected from the number of primary particle traversals. The effect was expressed as early as 15 min after exposure, peaked at 1 h and decreased by 24 h. A similar tendency occurred after exposure of the cell cultures to 0.2 cGy of 3.7 MeV α particles (LET ∼109 keV/μm) that targets ∼1.6% of nuclei, but not after 0.2 cGy from 290 MeV/u carbon ions (LET ∼13 keV/μm) by which, on average, ∼13% of the nuclei were hit, which highlights the importance of radiation quality in the induced effect. Simulations with the FLUKA multi-particle transport code revealed that fragmentation products, other than electrons, in cell cultures exposed to HZE particles comprise <1% of the absorbed dose. Further, the radial spread of dose due to secondary heavy ion fragments is confined to approximately 10-20 μm. Thus, the latter are unlikely to significantly contribute to stressful effects in cells not targeted by primary HZE particles

Trastuzumab-associated cardiac adverse effects in the Herceptin adjuvant trial.

PURPOSE: The purpose of this analysis was to investigate trastuzumab-associated cardiac adverse effects in breast cancer patients after completion of (neo)adjuvant chemotherapy with or without radiotherapy. PATIENTS AND METHODS: The Herceptin Adjuvant (HERA) trial is a three-group, multicenter, open-label randomized trial that compared 1 or 2 years of trastuzumab given once every 3 weeks with observation in patients with HER-2-positive breast cancer. Only patients who after completion of (neo)adjuvant chemotherapy with or without radiotherapy had normal left ventricular ejection fraction (LVEF > or = 55%) were eligible. A repeat LVEF assessment was performed in case of cardiac dysfunction. RESULTS: Data were available for 1,693 patients randomly assigned to 1 year trastuzumab and 1,693 patients randomly assigned to observation. The incidence of trastuzumab discontinuation due to cardiac disorders was low (4.3%). The incidence of cardiac end points was higher in the trastuzumab group compared with observation (severe congestive heart failure [CHF], 0.60% v 0.00%; symptomatic CHF, 2.15% v 0.12%; confirmed significant LVEF drops, 3.04% v 0.53%). Most patients with cardiac dysfunction recovered in fewer than 6 months. Patients with trastuzumab-associated cardiac dysfunction were treated with higher cumulative doses of doxorubicin (287 mg/m(2) v 257 mg/m(2)) or epirubicin (480 mg/m(2) v 422 mg/m(2)) and had a lower screening LVEF and a higher body mass index. CONCLUSION: Given the clear benefit in disease-free survival, the low incidence of cardiac adverse events, and the suggestion that cardiac dysfunction might be reversible, adjuvant trastuzumab should be considered for treatment of breast cancer patients who fulfill the HERA trial eligibility criteri

Expression of Msx-1 is suppressed in bisphosphonate associated osteonecrosis related jaw tissue-etiopathology considerations respecting jaw developmental biology-related unique features

<p>Abstract</p> <p>Background</p> <p>Bone-destructive disease treatments include bisphosphonates and antibodies against the osteoclast differentiator, RANKL (aRANKL); however, osteonecrosis of the jaw (ONJ) is a frequent side-effect. Current models fail to explain the restriction of bisphosphonate (BP)-related and denosumab (anti-RANKL antibody)-related ONJ to jaws. Msx-1 is exclusively expressed in craniofacial structures and pivotal to cranial neural crest (CNC)-derived periodontal tissue remodeling. We hypothesised that Msx-1 expression might be impaired in bisphosphonate-related ONJ. The study aim was to elucidate Msx-1 and RANKL-associated signal transduction (BMP-2/4, RANKL) in ONJ-altered and healthy periodontal tissue.</p> <p>Methods</p> <p>Twenty ONJ and twenty non-BP exposed periodontal samples were processed for RT-PCR and immunohistochemistry. An automated staining-based alkaline phosphatase-anti-alkaline phosphatase method was used to measure the stained cells:total cell-number ratio (labelling index, Bonferroni adjustment). Real-time RT-PCR was performed on ONJ-affected and healthy jaw periodontal samples (n = 20 each) to quantitatively compare Msx-1, BMP-2, RANKL, and GAPDH mRNA levels.</p> <p>Results</p> <p>Semi-quantitative assessment of the ratio of stained cells showed decreased Msx-1 and RANKL and increased BMP-2/4 (all p < 0.05) expression in ONJ-adjacent periodontal tissue. ONJ tissue also exhibited decreased relative gene expression for Msx-1 (p < 0.03) and RANKL (p < 0.03) and increased BMP-2/4 expression (p < 0.02) compared to control.</p> <p>Conclusions</p> <p>These results explain the sclerotic and osteopetrotic changes of periodontal tissue following BP application and substantiate clinical findings of BP-related impaired remodeling specific to periodontal tissue. RANKL suppression substantiated the clinical finding of impaired bone remodelling in BP- and aRANKL-induced ONJ-affected bone structures. Msx-1 suppression in ONJ-adjacent periodontal tissue suggested a bisphosphonate-related impairment in cellular differentiation that occurred exclusively jaw remodelling. Further research on developmental biology-related unique features of jaw bone structures will help to elucidate pathologies restricted to maxillofacial tissue.</p